Skip to main content

Table 2 Studies reporting AGWs in men

From: Prevalence, incidence and risk factors for anogenital warts in Sub Saharan Africa: a systematic review and meta analysis

Author, year

Country

Study design

Study population

Sample

Mean or Median age

Prevalence of AGWs2(%)

Prevalence of HIV-1%

Comments

size

(years, range/IQR1)

East Africa

Grijsen et al., 2008 [24]

Kenya

§Baseline of a prospective cohort study

Men at high-risk for HIV infection

536

27 (24–33)

9/500 (1.8)

21.0

 

Smith et al., 2010 [45]

Kenya

§Baseline of RCT3 on male circumcision

HIV negative sexually active men

2168

20 (19–28)

12/2168 (0.6) Overall 10/1089 (0.9) HIV + 2/1079 ( 0.2) HIV-

  

Tobian et al., 2012 [46]

Uganda

†Cross-sectional

Heterosexual men

1399

15-49

23/1399 (1.6)a Overall 16/421 (3.8)a HIV + 7/978 (0.7)a HIV –

  

Central and South Africa

Le Bacq et al., 1993 [31]

Zimbabwe

§Cross-sectional

New STD clinic attendees

319

 

39/319 (12.2)

61.0

 

Maher et al. 1995 [32]

Malawi

§Cross-sectional

In-patient male patients in general medical care

62

39 (20–90)

3/62 (4.8)

  

Machekano et al., 2000 [47]

Zimbabwe

§Baseline of prospective cohort study

Male factory workers who reported symptoms of STDs

374

 

22/374 (6.0)

20

 

Müller et al., 2010 [48]

South Africa

§Cross-sectional

Heterosexual men attending sexual health services

214

29.8 ± 7.5

108/214 (50.5)

49.5

 

West Africa

Okesola et al., 2000 [40]

Nigeria

§Cross-sectional

STD2 clinic attendees

1,373

17-74

4.1

  

Wade et al., 2005 [49]

Senegal

§Cross sectional

Men who have sex with men

463

18-52

13/463 (2.8)

18.1

21.5% Overall 0.5% HIV-2 2 2.9% HIV-1 & HIV-

  1. a Self-reported prevalence.
  2. 1Inter Quartile Range.
  3. 2Commercial sexual workers.
  4. 3Randomized Controlled Trial.
  5. §hospital-based study.
  6. †Population-based study.